Schwartz GK - Search Results

1

Targeting checkpoint kinase 1 in cancer therapeutics.

Tse AN, Carvajal R, Schwartz GK. Tse AN, et al. Among authors: schwartz gk. Clin Cancer Res. 2007 Apr 1;13(7):1955-60. doi: 10.1158/1078-0432.CCR-06-2793. Clin Cancer Res. 2007. PMID: 17404075 Review.

2

Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.

Schwartz GK, Jiang J, Kelsen D, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1993 Mar 3;85(5):402-7. doi: 10.1093/jnci/85.5.402. J Natl Cancer Inst. 1993. PMID: 8433394

3

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.

Hsueh CT, Kelsen D, Schwartz GK. Hsueh CT, et al. Among authors: schwartz gk. Clin Cancer Res. 1998 Sep;4(9):2201-6. Clin Cancer Res. 1998. PMID: 9748140

4

UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.

Husain A, Yan XJ, Rosales N, Aghajanian C, Schwartz GK, Spriggs DR. Husain A, et al. Among authors: schwartz gk. Clin Cancer Res. 1997 Nov;3(11):2089-97. Clin Cancer Res. 1997. PMID: 9815601

5

A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.

Schwartz GK, Ward D, Saltz L, Casper ES, Spiess T, Mullen E, Woodworth J, Venuti R, Zervos P, Storniolo AM, Kelsen DP. Schwartz GK, et al. Clin Cancer Res. 1997 Apr;3(4):537-43. Clin Cancer Res. 1997. PMID: 9815717 Clinical Trial.

6

Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.

Schwartz GK, Farsi K, Maslak P, Kelsen DP, Spriggs D. Schwartz GK, et al. Clin Cancer Res. 1997 Sep;3(9):1467-72. Clin Cancer Res. 1997. PMID: 9815832

7

Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.

Motwani M, Delohery TM, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Clin Cancer Res. 1999 Jul;5(7):1876-83. Clin Cancer Res. 1999. PMID: 10430095

8

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Among authors: schwartz gk. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

9

Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.

Motwani M, Li X, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Clin Cancer Res. 2000 Mar;6(3):924-32. Clin Cancer Res. 2000. PMID: 10741717

10

The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.

Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK. Koutcher JA, et al. Among authors: schwartz gk. Clin Cancer Res. 2000 Apr;6(4):1498-507. Clin Cancer Res. 2000. PMID: 10778982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters